Core Viewpoint - The company plans to distribute a cash dividend of 1.00 yuan per 10 shares for the first half of 2025, which represents 10.65% of the net profit attributable to shareholders [2][53]. Group 1: Profit Distribution Plan - The total number of shares after the cancellation of restricted stocks is 1,038,757,509, leading to a total cash dividend distribution of approximately 103.88 million yuan (including tax) [2][53]. - The remaining undistributed profits amount to approximately 5.90 billion yuan for the parent company and 9.73 billion yuan for the consolidated entity, which will be carried forward for future distribution [2]. - The profit distribution plan is subject to approval by the shareholders' meeting [3][55]. Group 2: Company Bond Issuance - The company plans to issue bonds with a total scale not exceeding 30 billion yuan, with specific issuance amounts to be determined based on market conditions and funding needs [17][60]. - The bonds will have a face value of 100 yuan each and will be issued at par [61]. - The funds raised will be used for repaying interest-bearing debts, supporting investments and acquisitions, and supplementing working capital [67][77]. Group 3: Company Overview and Financial Data - The company has a total share capital of 1,038,836,522 shares as of June 30, 2025 [2]. - The company’s financial condition is stable, with a good credit rating over the past three years [71]. - The company has been focusing on enhancing operational quality and increasing investment returns through various initiatives [78].

Core Viewpoint - The company is actively implementing the "Quality Improvement and Efficiency Enhancement Return" action plan to enhance its investment value and protect investors' rights, with significant progress reported in various operational areas [1][7]. Action Plan Execution - The company has established a special working leadership group to oversee the action plan, ensuring a focus on quality, efficiency, and investment returns [1]. - A comprehensive approach has been adopted, involving multiple departments to drive high-quality development and enhance investment value [1]. Measures Implementation Effects Improvement of Operational Quality - The company is focusing on dual drivers of R&D innovation and external development to enhance core competitiveness, with increased R&D investment and a shift from "technology-oriented" to "value-oriented" product development [2]. - Smart factory initiatives have been launched, resulting in increased production capacity and labor productivity [2]. - The company is pursuing mergers and acquisitions in targeted segments, with three product agreements completed [2]. Accelerating New Quality Productivity - The company is advancing its innovation transformation, having completed the first phase of its R&D strategy and is now moving into deeper strategic phases [3]. - A total of 15 projects are in progress, with significant breakthroughs in innovative drug development, including the launch of a pediatric microtablet formulation and clinical approvals for several oncology drugs [3]. Enhancing Corporate Governance - The company is optimizing its governance structure and has initiated revisions to core regulations to align with new legal requirements [4]. - The board structure is being improved, with a focus on enhancing oversight and integrating sustainable development into strategic planning [4]. Strengthening Responsibility of Key Personnel - A responsibility mechanism has been implemented to align performance incentives with company results, ensuring accountability among management [5]. - The company has activated a stock incentive plan to motivate key personnel and align their interests with company performance [5]. Increasing Investor Returns - The company has established a comprehensive market value management system, with a total cash dividend and share buyback amounting to 1.4 billion yuan over the past three years, achieving a cash dividend ratio of 84% [6]. - A semi-annual dividend distribution has been initiated to enhance shareholder returns [6]. Enhancing Investor Communication - The company is expanding its investor relations communication channels, including hybrid shareholder meetings and various interactive sessions to engage with investors [6]. - Innovative information dissemination methods are being employed to improve transparency and investor understanding of company performance [6]. Conclusion - The company is committed to continuously evaluating and optimizing the "Quality Improvement and Efficiency Enhancement Return" action plan to ensure effective implementation and adapt to market changes [7].